Zobrazeno 1 - 10
of 463
pro vyhledávání: '"Turpie AG"'
Publikováno v:
Vascular Health and Risk Management, Vol 2012, Iss default, Pp 363-370 (2012)
Alexander GG Turpie,1 André C Schmidt,2 Reinhold Kreutz,3 Michael R Lassen,4 Waheed Jama,1,2 Lorenzo Mantovani,5 Sylvia Haas61Department of Medicine, Hamilton Health Sciences, General Division, Ontario, Canada; 2Bayer Healthcare Pharmaceuticals, Glo
Externí odkaz:
https://doaj.org/article/88b182eee7c04546a2534b916d69ef44
Autor:
Verheugt, FW, Ambrosio, G, Atar, D, Bassand, J-P, Camm, AJ, Costabel, JP, Fitzmaurice, DA, Illingworth, L, Goldhaber, SZ, Goto, S, Haas, S, Jansky, P, Kayani, G, Stepinska, J, Turpie, AG, van Eickels, M, Kakkar, AK, GARFIELD-AF Investigators
BACKGROUND: Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in the need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::b177fae28897458e5c3c74c236024e75
https://openaccess.sgul.ac.uk/id/eprint/111045/1/1-s2.0-S0002934319305431-main.pdf
https://openaccess.sgul.ac.uk/id/eprint/111045/1/1-s2.0-S0002934319305431-main.pdf
Aims: In Europe, the approved rivaroxaban dose for stroke prevention in patients with atrial fibrillation is 20 mg once daily (od), with 15 mg od recommended in patients with creatinine clearance [CrCl] 15-49 mL/min. Non-recommended doses are prescri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::9e4122ef73126545f00a01c0ee230d99
https://openaccess.sgul.ac.uk/id/eprint/110406/1/pvy041.pdf
https://openaccess.sgul.ac.uk/id/eprint/110406/1/pvy041.pdf
Autor:
Eriksson, Bi, Turpie, Ag, Lassen, Mr, Prins, Mh, Agnelli, G, Kälebo, P, Wetherill, G, Wilpshaar, Jw, Meems, L, Paireddy, A, Wall, M, Hermus, G, Willems, M, Zachrisson, B, Wallin, J, Eriksson, H, Sandgren, G, Angerås, U, Falk, A, Bergqvist, D, Gallus, A, Tijssen, Jg, Pessayre, D, Grohs, Jg, Nogler, M, Wurnig, C, Gavrankapetanovic, I, Maric, V, Pavic, V, Deniger, J, Kofránek, I, Pink, M, Pink, T, Hölmich, P, Mejdahl, S, Mikkelsen, S, Leppilahti, J, Pesola, M, Fink, B, Göbel, F, Graichen, H, Halder, Am, Kienapfel, H, Kurth, A, Ferrousis, I, Macheras, G, D'Angelo, A, Baudo, F, Borghi, B, Della Rocca, G, Fanelli, G, Grappiolo, G, Grossi, P, Piovella, F, Silingardi, M, Spotorno, L, Baurovskis, A, Keselis, J, Peredistijs, A, Kocius, M, Smailys, A, Buciuto, R, Hedlund, T, Talsnes, O, Bednarek, A, Blacha, J, Kwiatkowski, K, Niedzwiedzki, T, Skowronski, Jc, Wojciechowski, P, Dryagin, V, Ivanov, P, Kopenkin, S, Kuropatkin, G, Lapshinov, E, Levin, G, Linnik, S, Medvedev, A, Nikolaev, V, Safronov, A, Sergeev, S, Harhaji, V, Kecojevic, V, Mitkovic, M, Nedeljkovic, R, Ristic, B, Stosic, P, Todorovic, P, Hlavác, M, Oslanec, D, Alonso Aguirre MA, Casa Pantoja, V, Cruz Pardos, A, Díaz Almodovar JL, Gomar Sancho, F, Otero Fernández, R, Valle Ortiz MJ, Vilanova Vázquez JL, Ahnfelt, L, Andersson, C, Petersson, Lg, Ponzer, S.
Publikováno v:
Journal of thrombosis and haemostasis, 8(4), 714-721. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 8(4), 714-721. Wiley
Journal of Thrombosis and Haemostasis, 8(4), 714-721. Wiley
Summary. Background: Anticoagulant prophylaxis substantially reduces the risk of venous thromboembolism (VTE) after major orthopedic surgery. The direct factor Xa inhibitor YM150 is currently under investigation for the prevention of VTE, stroke and
Autor:
Kakkar, Ak, Agnelli, Giancarlo, Fisher, W, George, D, Lassen, Mr, Mismetti, P, Mouret, P, Murphy, J, Lawson, F, Turpie, Ag, SAVE ABDO Investigators
Publikováno v:
Annals of Surgery. 259:1073-1079
Objective To compare efficacy and safety of thromboprophylaxis with semuloparin started postoperatively versus enoxaparin started preoperatively in major abdominal surgery. Background Venous thromboembolism is an important complication following majo
Autor:
Nicolaides, An, Fareed, J, Kakkar, Ak, Comerota, Aj, Goldhaber, Sz, Hull, R, Myers, K, Samama, M, Fletcher, J, Kalodiki, E, Bergqvist, D, Bonnar, J, Caprini, Ja, Carter, C, Prandoni, Paolo, Conard, J, Eklof, B, Elalamy, I, Gerotziafas, G, Geroulakos, G, Giannoukas, A, Greer, I, Griffin, M, Kakkos, S, Lassen, Mr, Lowe, Gd, Markel, A, Raskob, G, Spyropoulos, Ac, Turpie, Ag, Walenga, Jm, Warwick, D.
Publikováno v:
International angiology : a journal of the International Union of Angiology. 32(2)
The aim of this document is to provide a clear and concise account of the evidence regarding efficacy or harm for various methods available to prevent and manage venous thromboembolism (VTE).
Autor:
Poller, L, Keown, M, Ibrahim, S, Lowe, G, Moia, M, Turpie, Ag, Roberts, C, van den Besselaar AM, van der Meer FJ, Tripodi, A, Palareti, G, Shiach, C, Bryan, S, Samama, M, Burgess Wilson, M, Heagerty, A, Maccallum, P, Wright, D, Jespersen, J, European Action on Anticoagulation Collaborators, Munster, Am, Leed, B, Bowyer, C, Chillou, C, Defard, M, Halkin, H, Loebstein, R, Naparstek, E, Kirgner, I, Peternel, P, Krevel, B, Stegnar, M, Marques Dias, D, Ageno, Walter, Dentali, Francesco, Watzke, H, Weisser, B, Angeles Fernandez, M, Chatelain, B, Cornet, I, Gallus, As, Osmond, J, Luckit, J, Charles, F.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3660::7ab0c1df61c5e81bb35b99371415528d
http://hdl.handle.net/11383/1717394
http://hdl.handle.net/11383/1717394
Autor:
Lassen, Mr, Ageno, W, Borris, Lc, Lieberman, Jr, Rosencher, N, Bandel, Tj, Misselwitz, F, Turpie, Ag, DELLA ROCCA, Giorgio, Record, Investigators
We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty.In this randomized, double-blind trial, 2531 patients who were to undergo total knee arthroplasty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa4799f025344bae65bc03b0363baac
http://hdl.handle.net/11383/1761710
http://hdl.handle.net/11383/1761710